tiprankstipranks
Trending News
More News >
International Stem Cell (ISCO)
OTHER OTC:ISCO
US Market

International Stem Cell (ISCO) Income Statement

Compare
43 Followers

International Stem Cell Income Statement

Last quarter (Q1 2025), International Stem Cell's total revenue was $2.13M, a decrease of 0.00% from the same quarter last year. In Q1, International Stem Cell's net income was $-256.00K. See International Stem Cell’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 9.09M$ 7.79M$ 8.18M$ 7.18M$ 7.13M
Gross Profit
$ 5.32M$ 4.61M$ 4.91M$ 4.24M$ 4.35M
Operating Expenses
$ 5.39M$ 5.27M$ 5.09M$ 6.16M$ 7.17M
Depreciation and Amortization
$ 206.00K$ 194.00K$ 359.00K$ 551.00K$ 253.00K
EBITDA
$ 142.00K$ 202.00K$ 22.00K$ -220.00K$ -2.36M
Operating Income
$ -68.00K$ -663.00K$ -196.00K$ -1.92M$ -2.82M
Other Income/Expenses
$ -141.00K$ 532.00K$ -148.00K$ 1.02M$ 94.00K
Pretax Income
$ -209.00K$ -131.00K$ -331.00K$ -899.00K$ -2.72M
Net Income
$ -209.00K$ -131.00K$ -466.00K$ -1.04M$ -2.84M
Per Share Metrics
Basic EPS
$ -0.03$ -0.02$ -0.06$ -0.13$ -0.38
Diluted EPS
$ -0.03$ -0.02$ -0.06$ -0.13$ -0.38
Weighted Average Shares Outstanding
8.00M 8.00M 8.00M 7.83M 7.54M
Weighted Average Shares Outstanding (Diluted)
8.00M 8.00M 8.00M 7.83M 7.54M
Currency in USD

International Stem Cell Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis